Advertisement
Home 2015

Archives

The first U.S. generic version of Copaxone (glatiramer acetate injection) has been approved by the Food and Drug Administration to treat multiple sclerosis.

FDA: Generic Copaxone Approved for Multiple Sclerosis

0
FDA reviewed additional information to ensure generic is as safe and effective as brand-name drug
A new modified timolol-based cream seems effective for infantile hemangiomas

Modified Timolol Agent Effective for Infantile Hemangiomas

0
After average of 3.25 months, treated parts regressed significantly more than untreated parts
Looking up students on Facebook and other social networking sites is associated with ethical concerns

Ethical Implications for Looking Up Applicants on Facebook

0
Misinterpretation of content, implicit bias could undermine fair appraisal for applicants
For men diagnosed with prostate cancer aged older than 70 years

Prolonged ADT Ups Diabetes, CVD Risk for Older Men

0
Prolonged androgen deprivation tx ups risk in men with prostate CA, especially those with comorbidities
Fish oil supplementation is associated with atherothrombotic risk reduction in suspected coronary artery disease

Fish Oil Supplementation Tied to Lower Atherothrombotic Risk

0
Potential benefit in suspected CAD greatest for patients not receiving lipid-lowering tx
Most U.S. adults would prefer to be asked for permission to participate in studies assessing usual medical practices

Survey Looks at Patient Attitudes Regarding Informed Consent

0
Most respondents want to be asked for permission to participate in studies assessing medical practice
For patients with single-level symptomatic cervical disc disease

Cervical Disc Arthroplasty Tops ACDF for Single-Level Cervical Dz

0
Lower readmission rates, lower reoperation rates, reduced index and total costs for CDA
For patients with knee osteoarthritis

Meta-Analysis: Valgus Knee Bracing Helps Pain in Knee OA

0
Small, statistically significant effect for pain compared with group that used control orthosis
Fifteen-year survival is comparable for bioprosthetic and mechanical prosthetic valve replacement

Longevity of Bioprosthetic Valve Replacement Assessed

0
15-year survival similar for patients using mechanical prosthetic, bioprosthetic replacement valves
Children with poor metabolizer phenotype based on CYP2C19 have worse asthma control after six months of lansoprazole treatment

Lansoprazole Worsens Asthma Control in Poor Metabolizers

0
After six months of treatment, worse control in children with poor CYP2C19 metabolizer phenotype